Key result
Low serum magnesium is linked to higher all-cause and CV mortality in haemodialysis patients.
Cohort (n=206)
Answers are grounded in this paper and cite their sources.
BACKGROUND: Hypomagnesaemia is a cardiovascular (CV) risk factor in the general population. The aim of this study was to evaluate the relationship between pre-dialysis magnesium (Mg) and CV risk markers, [including pulse pressure (PP), left ventricular mass index (LVMI) and vascular calcifications (VC)], and mortality in haemodialysis (HD) patients. METHODS: We performed a 48-month prospective study in 206 patients under pre-dilution haemodiafiltration with a dialysate Mg concentration of 1 mmol/l. RESULTS: Lower Mg concentrations were predictors of an increased PP (≥65 mm Hg) (p = 0.002) and LVMI (≥140 g/m(2)) (p = 0.03) and of a higher VC score (≥3) (p = 0.01). Patients with Mg <1.15 mmol/l had a lower survival at the end of the study (p = 0.01). Serum Mg <1.15 mmol/l was an independent predictor of all-cause (p = 0.01) and CV mortality (p = 0.02) when adjusted for multiple CV risk factors. CONCLUSIONS: Lower Mg levels seem to be associated with increased CV risk markers, like PP, LVMI and VC, and with higher mortality in HD patients.
No takes yet. Share an insight, caveat, or question.
Azevedo et al. (2014) conducted a cohort in Haemodialysis patients (n=206). Pre-dialysis serum magnesium <1.15 mmol/l vs. Pre-dialysis serum magnesium ≥1.15 mmol/l was evaluated on All-cause and cardiovascular mortality (p=0.01 (all-cause mortality); 0.02 (CV mortality)). Serum magnesium <1.15 mmol/l independently predicted increased all-cause and cardiovascular mortality in haemodialysis patients.
Synapse has enriched 10 related papers. Consider them for comparative context: